imiquimod has been researched along with curcumin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 9 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hu, J; Sun, J; Zhao, Y | 1 |
| Bajek, A; Czajkowski, R; Drewa, T; Schwartz, RA; Uzarska, M; Zegarska, B | 1 |
| Domb, AJ; Doppalapudi, S; Jain, A; Khan, W | 1 |
| M, R; Mishra, A; P, R; Prabhu, S; Sivaprakasam, TO; Varma, SR | 1 |
| Chuang, TH; Hsu, LC; Lai, CY; Lin, KI; Su, YW | 1 |
| Kang, NW; Kim, DD; Kim, KT; Kim, MH; Lee, JY; Lee, SY; Park, JH; Sohn, SY | 1 |
| Cun, D; Lin, Z; Liu, Z; Sun, L; Tong, HH; Wang, R; Yan, R; Zheng, Y | 1 |
| Blontzos, N; Douligeris, A; Fotiou, A; Iavazzo, C; Karavioti, E; Prodromidou, A; Psomiadou, V; Vorgias, G | 1 |
| Balamuralidhara, V; Gupta, NV; Iriventi, P; Osmani, RAM | 1 |
| Ahmad, J; Ahmad, MZ; Algahtani, MS; Nourein, IH | 1 |
| Chen, Y; Geng, Y; Lai, S; Wang, J; Zhang, S; Zhou, T; Zhou, Y | 1 |
| Abdellatif, AAH; Abdulmonem, WA; Al Rugaie, O; Alhumaydhi, FA; Aljasir, M; Aljohani, ASM; AlKhowailed, MS; Alnuqaydan, AM; Alsagaby, SA; Alsuhaibani, SA; Alwashmi, ASS; Babiker, AY; Elsheikh, SY; Hegazy, AMS; Mousa, AM; Seleem, HS; Soliman, KEA; Yosof, MYR | 1 |
| Chen, J; Chen, R; Jin, N; Li, Y; Zhang, B; Zhang, Z | 1 |
| Cai, Z; Wang, W; Zeng, Y; Zhang, Y | 1 |
| Arora, N; Pandey-Rai, S; Shah, K | 1 |
| Han, L; He, R; Li, B; Lin, Y; Liu, Q; Lu, C; Lv, J; Mi, Q; Yin, W | 1 |
| He, D; Li, JQ; She, SY; Tong, RS; Zhang, SH; Zhong, ZD | 1 |
2 review(s) available for imiquimod and curcumin
| Article | Year |
|---|---|
Chemoprevention of skin melanoma: facts and myths.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Flavonoids; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Pigmentation; Randomized Controlled Trials as Topic; Resveratrol; Retinoids; Risk; Skin; Skin Neoplasms; Stilbenes; Tea; Treatment Outcome; Vitamin D | 2013 |
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cytokines; Dermatitis; Endosomes; Humans; Imiquimod; Indazoles; Isonicotinic Acids; Mice; Psoriasis; Resveratrol; Signal Transduction; Skin; Stilbenes; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors | 2017 |
16 other study(ies) available for imiquimod and curcumin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Topics: Aminoquinolines; Animals; Cell Proliferation; Curcumin; Ear; Gene Expression Regulation; Imiquimod; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Psoriasis; Receptors, Antigen, T-Cell, gamma-delta; Receptors, CCR6; RNA, Messenger; Skin | 2013 |
Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Chemistry, Pharmaceutical; Curcumin; Delayed-Action Preparations; Dermatologic Agents; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Gels; Imiquimod; Immunosuppressive Agents; Lipids; Male; Mice; Mice, Inbred BALB C; Particle Size; Psoriasis; Tacrolimus; Tissue Distribution | 2016 |
Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Topics: Aminoquinolines; Biomarkers; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Curcumin; Cytokines; Drug Evaluation, Preclinical; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Molecular Docking Simulation; Protein Conformation; Psoriasis; Skin | 2017 |
Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Curcumin; Dermatitis; Drug Carriers; Imiquimod; Lipids; Male; Mice; Nanofibers; Psoriasis | 2018 |
Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Disease Models, Animal; Female; Imiquimod; Mice; Mice, Inbred C57BL; Nanoparticles; Psoriasis; Skin | 2018 |
An Alternative Treatment for Vaginal Cuff Wart: a Case Report.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; beta-Glucans; Colposcopy; Condylomata Acuminata; Curcumin; Drug Combinations; Fatty Alcohols; Female; Humans; Imiquimod; Lactic Acid; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Phyllanthus emblica; Phytotherapy; Plant Preparations; Squamous Intraepithelial Lesions of the Cervix; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2020 |
Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis.
Topics: Administration, Topical; Animals; beta-Cyclodextrins; Caffeine; Curcumin; Delayed-Action Preparations; Disease Models, Animal; Drug Combinations; Drug Compounding; Female; Formates; Imiquimod; Male; Mice; Nanostructures; Particle Size; Psoriasis | 2020 |
Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions.
Topics: Administration, Topical; Animals; Curcumin; Disease Models, Animal; Drug Combinations; Drug Compounding; Emulsions; Imiquimod; Male; Mice; Mice, Inbred BALB C; Nanogels; Oleic Acid; Particle Size; Permeability; Polyethylene Glycols; Polyethyleneimine; Polysorbates; Psoriasis; Rats | 2020 |
Curcumin alleviates imiquimod-induced psoriasis in progranulin-knockout mice.
Topics: Animals; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Imiquimod; Interleukin-17; Keratinocytes; Male; Mice; Mice, Knockout; Progranulins; Psoriasis | 2021 |
Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Curcumin; Cytokines; Disease Models, Animal; Imiquimod; Interleukin-12 Subunit p40; Interleukin-17; Psoriasis; Rats; Skin; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Ustekinumab | 2022 |
Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation.
Topics: Curcumin; Glycyrrhizic Acid; Humans; Imiquimod; Psoriasis; Silicon Dioxide | 2023 |
Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice.
Topics: Animals; Curcumin; Dermatitis; Gastrointestinal Microbiome; Imiquimod; Inflammation; Interleukin-23; Mice; Tumor Necrosis Factor-alpha | 2023 |
Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants.
Topics: Aloe; Aminoquinolines; Animals; Celastrus; Curcuma; Cytokines; Dermatitis, Contact; Drug Evaluation, Preclinical; Gene Expression; Imiquimod; Male; Mice; Plant Extracts; Plant Stems; Plants, Medicinal; Psoriasis; Skin; Tinospora | 2016 |
Diarylheptanoid from rhizomes of Curcuma kwangsiensis (DCK) inhibited imiquimod-induced dendritic cells activation and Th1/Th17 differentiation.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Curcuma; Dendritic Cells; Diarylheptanoids; Imiquimod; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Rhizome; Th1 Cells; Th17 Cells | 2018 |
Curcuma's extraction attenuates propranolol-induced psoriasis like in mice by inhibition of keratin, proliferating cell nuclear antigen and toll-like receptor expression.
Topics: Animals; Curcuma; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Female; Guinea Pigs; Imiquimod; Keratins; Male; Mice; Mitosis; Plant Extracts; Proliferating Cell Nuclear Antigen; Propranolol; Psoriasis; Rhizome; Skin; Time Factors; Toll-Like Receptors; Vagina | 2020 |